Journal of Developmental Biology,
Journal Year:
2022,
Volume and Issue:
10(3), P. 31 - 31
Published: July 27, 2022
Protein
kinase
CK2
(CK2)
is
a
ubiquitous
holoenzyme
involved
in
wide
array
of
developmental
processes.
The
involvement
events
such
as
neurogenesis,
cardiogenesis,
skeletogenesis,
and
spermatogenesis
essential
for
the
viability
almost
all
organisms,
its
role
has
been
conserved
throughout
evolution.
Further
into
adulthood,
continues
to
function
key
regulator
pathways
affecting
crucial
processes
osteogenesis,
adipogenesis,
chondrogenesis,
neuron
differentiation,
immune
response.
Due
vast
multitude
pathways,
aberrant
functioning
this
leads
embryonic
lethality
numerous
diseases
disorders,
including
cancer
neurological
disorders.
As
result,
popular
target
interventions
aiming
treat
aforementioned
diseases.
Specifically,
two
inhibitors,
namely
CX-4945
CIBG-300,
are
early
stages
clinical
testing
exhibit
promise
treating
other
Further,
researchers
around
world
focusing
on
bone
This
review
summarizes
current
understanding
development,
structure
CK2,
targets
signaling
implication
disease
progression,
recent
therapeutics
developed
inhibit
dysregulation
various
Biomedicines,
Journal Year:
2022,
Volume and Issue:
10(8), P. 1987 - 1987
Published: Aug. 16, 2022
Cancer
is
a
leading
cause
of
death
worldwide.
Casein
kinase
2
(CK2)
commonly
dysregulated
in
cancer,
impacting
diverse
molecular
pathways.
CK2
highly
conserved
serine/threonine
kinase,
constitutively
active
and
ubiquitously
expressed
eukaryotes.
With
over
500
known
substrates
being
estimated
to
be
responsible
for
up
10%
the
human
phosphoproteome,
it
significant
importance.
A
broad
spectrum
types
cancer
cells
has
been
already
shown
rely
on
disturbed
levels
their
survival.
The
hallmarks
provide
rationale
understanding
cancer's
common
traits.
They
constitute
maintenance
proliferative
signaling,
evasion
growth
suppressors,
resisting
cell
death,
enabling
replicative
immortality,
induction
angiogenesis,
activation
invasion
metastasis,
as
well
avoidance
immune
destruction
dysregulation
cellular
energetics.
In
this
work,
we
have
compiled
evidence
from
literature
suggesting
that
modulates
all
thereby
promoting
oncogenesis
operating
driver
by
creating
environment
favorable
neoplasia.
Scientific Reports,
Journal Year:
2022,
Volume and Issue:
12(1)
Published: Oct. 21, 2022
Abstract
Chronic
lymphocytic
leukemia
(CLL)
is
an
incurable
malignancy
of
B-cells.
In
this
study,
bioinformatics
analyses
were
conducted
to
identify
possible
pathogenic
roles
CK2α,
which
a
protein
encoded
by
CSNK2A1
,
in
the
progression
and
aggressiveness
CLL.
Furthermore,
various
computational
tools
used
search
for
competent
inhibitor
CK2α
from
fungal
metabolites
that
could
be
proposed
CLL
therapy.
patients,
high-expression
was
associated
with
early
need
therapy
(n
=
130,
p
<
0.0001)
short
overall
survival
(OS;
n
107,
0.005).
Consistently,
showed
associate
with/play
proliferation
survival-dependent
pathways.
PPI
network
analysis
identified
interaction
partners
(PPI
enrichment
value
1
×
10
–16
)
0.003)
have
been
known
heavily
impact
on
These
findings
constructed
rational
targeting
Consequently,
reported
35
out
5820
(filtered
19,967
metabolites)
lower
binding
energy
(ΔG:
−
10.9
11.7
kcal/mol)
better
affinity
(Kd:
9.77
7
M
−1
3.77
8
compared
native
ligand
10.8,
Kd:
8.3
M−
).
molecular
dynamics
simulation
study
established
Butyl
Xanalterate-CK2α
complex
continuously
remained
stable
throughout
time
(100
ns).
Moreover,
Xanalterate
interacted
most
catalytic
residues,
where
stabilized
more
than
65%
hydrogen
bond
interactions,
significant
hydrophobic
residue
Phe113.
Here,
implicated
poor
prognosis
CLL,
making
it
potential
therapeutic
target
disease.
strong
interactions
thus
we
propose
as
competitive
ACS Chemical Biology,
Journal Year:
2022,
Volume and Issue:
17(7), P. 1937 - 1950
Published: June 19, 2022
Inhibition
of
the
protein
kinase
CSNK2
with
any
30
specific
and
selective
inhibitors
representing
different
chemotypes,
blocked
replication
pathogenic
human,
bat,
murine
β-coronaviruses.
The
potency
in-cell
CSNK2A
target
engagement
across
set
correlated
antiviral
activity
genetic
knockdown
confirmed
essential
role
holoenzyme
in
β-coronavirus
replication.
Spike
endocytosis
was
by
inhibition,
indicating
that
due
part
to
a
suppression
viral
entry.
inhibition
may
be
viable
for
development
anti-SARS-like
drugs.
Journal of Developmental Biology,
Journal Year:
2022,
Volume and Issue:
10(3), P. 31 - 31
Published: July 27, 2022
Protein
kinase
CK2
(CK2)
is
a
ubiquitous
holoenzyme
involved
in
wide
array
of
developmental
processes.
The
involvement
events
such
as
neurogenesis,
cardiogenesis,
skeletogenesis,
and
spermatogenesis
essential
for
the
viability
almost
all
organisms,
its
role
has
been
conserved
throughout
evolution.
Further
into
adulthood,
continues
to
function
key
regulator
pathways
affecting
crucial
processes
osteogenesis,
adipogenesis,
chondrogenesis,
neuron
differentiation,
immune
response.
Due
vast
multitude
pathways,
aberrant
functioning
this
leads
embryonic
lethality
numerous
diseases
disorders,
including
cancer
neurological
disorders.
As
result,
popular
target
interventions
aiming
treat
aforementioned
diseases.
Specifically,
two
inhibitors,
namely
CX-4945
CIBG-300,
are
early
stages
clinical
testing
exhibit
promise
treating
other
Further,
researchers
around
world
focusing
on
bone
This
review
summarizes
current
understanding
development,
structure
CK2,
targets
signaling
implication
disease
progression,
recent
therapeutics
developed
inhibit
dysregulation
various